ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Valerio Therapeutics

Valerio Therapeutics (ALVIO)

0.10
0.001
(1.01%)
Closed July 20 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.10
Bid
0.099
Ask
0.10
Volume
59,786
0.10 Day's Range 0.1024
0.09 52 Week Range 0.348
Market Cap
Previous Close
0.099
Open
0.1008
Last Trade
2056
@
0.1
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
77,994
Shares Outstanding
154,364,273
Dividend Yield
-
PE Ratio
-9.71
Earnings Per Share (EPS)
-0.13
Revenue
4.45M
Net Profit
-20.34M

About Valerio Therapeutics

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
Headquarters
Paris, Paris, Fra
Founded
1970
Valerio Therapeutics is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker ALVIO. The last closing price for Valerio Therapeutics was 0.10 €. Over the last year, Valerio Therapeutics shares have traded in a share price range of 0.09 € to 0.348 €.

Valerio Therapeutics currently has 154,364,273 shares outstanding. The market capitalization of Valerio Therapeutics is 15.28 € million. Valerio Therapeutics has a price to earnings ratio (PE ratio) of -9.71.

ALVIO Latest News

Valerio Therapeutics : compte rendu de l’assemblée générale mixte du 4 juin 2024

Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après « Valerio Therapeutics » ou « la Société », société de biotechnologie au stade clinique spécialisée dans le...

Valerio Therapeutics Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial

The first dose level, evaluating 3 patients of the VIO-01-101 trial has been cleared as per the recommendations of the Clinical Review Committee. No clinically significant adverse events or...

Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates

Cash position of €6.8 million as of December 31, 2023 Financial visibility until the end of fourth quarter of 2024 Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO...

Valerio Therapeutics Announces a Capital Reduction Motivated by Losses by Reducing the Nominal Value of the Company's Shares

Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), hereafter “Valerio Therapeutics” or the “Company”, a clinical-stage biotechnology company specializing in the...

Half-Year Liquidity Contract Statement for Valerio Therapeutics

Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) Under the liquidity contract entered into between Valerio Therapeutics and Kepler Cheuvreux, the following resources...

Valerio Therapeutics Reports its Half-Year 2023 Financial Results and Provides an Update on its Activities

New identity unveiled, with the aim at developing innovative therapies against cancer R&D efforts maintained for VIO-01 (formerly OX425) and AsiDNATM Optimization of PlatONTM platform...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0004-0.3984063745020.10040.10480.099443640.10019335DE
4-0.002-1.960784313730.1020.10540.099499690.10156184DE
12-0.016-13.79310344830.1160.1240.099779940.10730116DE
26-0.0345-25.65055762080.13450.14250.09901150.11477824DE
52-0.14-58.33333333330.240.3480.09861210.17269725DE
156-0.173-63.369963370.2730.3480.09817060.17631918DE
260-0.173-63.369963370.2730.3480.09817060.17631918DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
AUGXAugmedix Inc
$ 2.27
(147.71%)
24.14M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.8M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.45k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.63M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
223.27k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.93M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
28.43M
SERVServe Robotics Inc
$ 7.51
(185.55%)
262.73M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
206.41M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
202.14M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
184.21M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
119.98M

Discussion

View Full Feed
TrendTrade2016 TrendTrade2016 5 minutes ago
LOI SCAM...IN 2024 NOT 1 LOI CAME THROUGH AND ABBA DADDA ALI BOU JABBA AND HIS BUDDIES ARE LAUGHING AT THE CLOWNS
HIRU
misterfishman misterfishman 7 minutes ago
Oh i woke up early to go to work on overtime so wrote that on my lab laptop.
RONN
trader53 trader53 7 minutes ago
INCT Reverse Stock Split is July 30, 2024


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
___________________________________________________



On July 16 , 2024

Supplemental Information Disclosure
INCT MFI
TrendTrade2016 TrendTrade2016 8 minutes ago
weekly is a disaster...churn the road block rinse as owner uses this toxic garbage as his atm!!
HIRU
trader53 trader53 8 minutes ago
INCT Reverse Stock Split is July 30, 2024


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
___________________________________________________



On July 16 , 2024

Supplemental Information Disclosure
INCT MFI
Bull_Dolphin Bull_Dolphin 10 minutes ago
Once again, WOW. Thanks for this longer version!
How can this be argued against?
Oh that's right, we only trust the science when it agrees with the narrative.
misterfishman misterfishman 11 minutes ago
True that.
IGPK
MightyX MightyX 14 minutes ago
All these shares-traded past-weeks were trader-group-fraud alongside their slander/libel.
TPTW
MightyX MightyX 16 minutes ago
More to follow
TPTW
MightyX MightyX 17 minutes ago
Restricted OS increased significantly over 2B..not retail
TPTW
Juntao Juntao 17 minutes ago
DNAX .0002 https://www.otcmarkets.com/stock/DNAX/security
DNAX
MightyX MightyX 18 minutes ago
Trader groups getting passed up for new shares.
TPTW
Truth_is_a_tool Truth_is_a_tool 23 minutes ago
“I have been waiting for fourteen years.”

omg You’ve been invested in this penny stock , Kblb, for 14 years, just waiting for a ROI ?! Man , I would NOT be bragging about that lol Do you realize how much money you’ve probably lost over the years by having your money tied up here in
KBLB
Nesurk Nesurk 25 minutes ago
Hi 4retire, I am still here. I hope all is well with you. Seems like a lifetime ago that I first bought my initial shares back in the late nineties. I have added through the years, decades....lol.

I am just waiting for the TMMI movie to come out...lol
TMMI
ALDRADJKD123 ALDRADJKD123 26 minutes ago
Things just aren’t adding up,

https://youtu.be/rXQBIr96vyU?si=nvsPS6QXWinm07mo

And remember, there was a large short position taken out before the assassination attempt.
SkeBallLarry SkeBallLarry 31 minutes ago
Bob Baffert Churchill Downs suspension lifted after 3 years.
reindlll reindlll 33 minutes ago
Double posz
IGEN
reindlll reindlll 33 minutes ago
Question or fact?
IGEN
floridaboy floridaboy 34 minutes ago
Good to see another filing...
MEDH
Iggy_Bot Iggy_Bot 37 minutes ago
GM, y/w, I didn't even know she was sick..
Diamondhands45 Diamondhands45 40 minutes ago
Add to longs or shorts moon? Thank you so much for all the TA
TSLA
rocketeer357 rocketeer357 41 minutes ago
Mets need to learn to count to 7. 6 ain't enough.
dennisdave dennisdave 42 minutes ago
You know this isn’t just about L, it’s about the platform set up what platform? There has been platform talk for years now without NWBO conducting any active new DCVAX medical trial. This platform talk is a big BS without NWBO pursuing any DCVAX medical trial. That is because NWBO is too busy invest
NWBO

Your Recent History

Delayed Upgrade Clock